# Exozymes Inc.: filings

EXOZ · Nasdaq · CIK 2010788 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/exoz.md) · [Financials](/companies/exoz/financials.md) · [Filings](/companies/exoz/filings.md) · [Insiders](/companies/exoz/insiders.md)

## Reports and events: 45 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 25, 8-K 22, CORRESP 13, 3 12, S-1/A 8, 10-Q 6, UPLOAD 6, 424B5 5, SC 13D 4, 424B3 3, 10-K 2, 424B4 2, DEF 14A 2, EFFECT 2, FWP 2, S-8 2, 424B2 1, 4/A 1, 8-A12B 1, CERT 1, D 1, DEFA14A 1, DEFR14A 1, DRS 1, S-1 1, S-3 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-09 | 12:10 ET | [8-K](/filings/0001493152-26-046456.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-046456 |
| 2026-09-28 | 17:25 ET | [DEF 14A](/filings/0001140361-26-037859.md) | Proxy statement, period 2026-11-13 | 0001140361-26-037859 |
| 2026-09-18 | 13:24 ET | [8-K](/filings/0001493152-26-043288.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-043288 |
| 2026-08-13 | 15:50 ET | [10-Q](/filings/0001493152-26-037725.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037725 |
| 2026-07-01 | 16:30 ET | [8-K](/filings/0001493152-26-031560.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-031560 |
| 2026-06-26 | 19:36 ET | [8-K](/filings/0001493152-26-030205.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030205 |
| 2026-06-17 | 17:11 ET | [8-K](/filings/0001493152-26-029119.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-029119 |
| 2026-06-08 | 14:19 ET | [8-K](/filings/0001493152-26-027688.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027688 |
| 2026-05-14 | 15:50 ET | [10-Q](/filings/0001493152-26-023035.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023035 |
| 2026-05-07 | 06:08 ET | [8-K](/filings/0001493152-26-021589.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-021589 |
| 2026-04-10 | 17:27 ET | [8-K](/filings/0001493152-26-016227.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-016227 |
| 2026-03-31 | 06:12 ET | [8-K](/filings/0001493152-26-013733.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-013733 |
| 2026-03-30 | 17:29 ET | [10-K](/filings/0001493152-26-013563.md) | Annual report, period 2025-12-31 | 0001493152-26-013563 |
| 2026-02-05 | 21:30 ET | [8-K](/filings/0001493152-26-005176.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005176 |
| 2025-12-12 | 19:43 ET | [8-K](/filings/0001493152-25-027327.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-027327 |
| 2025-11-13 | 16:06 ET | [8-K](/filings/0001493152-25-022295.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-022295 |
| 2025-11-13 | 16:05 ET | [10-Q](/filings/0001493152-25-022289.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022289 |
| 2025-10-03 | 15:47 ET | [8-K](/filings/0001493152-25-016831.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-016831 |
| 2025-08-12 | 16:11 ET | [10-Q](/filings/0001641172-25-023184.md) | Quarterly report, period 2025-06-30 | 0001641172-25-023184 |
| 2025-07-28 | 06:05 ET | [8-K](/filings/0001641172-25-021084.md) | 5.07 Shareholder vote results | 0001641172-25-021084 |
| 2025-07-08 | 18:12 ET | [8-K](/filings/0001641172-25-018053.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-018053 |
| 2025-06-26 | 16:58 ET | [8-K](/filings/0001641172-25-016681.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-016681 |
| 2025-06-20 | 17:24 ET | [DEF 14A](/filings/0001140361-25-023217.md) | Proxy statement, period 2025-07-25 | 0001140361-25-023217 |
| 2025-06-20 | 13:28 ET | [8-K](/filings/0001641172-25-015782.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-015782 |
| 2025-05-12 | 14:34 ET | [10-Q](/filings/0001641172-25-009636.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009636 |
| 2025-04-02 | 16:30 ET | [8-K](/filings/0001641172-25-002396.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002396 |
| 2025-04-02 | 16:30 ET | [8-K](/filings/0001641172-25-002394.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002394 |
| 2025-03-31 | 16:17 ET | [10-K](/filings/0001641172-25-001744.md) | Annual report, period 2024-12-31 | 0001641172-25-001744 |
| 2025-02-21 | 16:36 ET | [8-K](/filings/0001493152-25-007884.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-007884 |
| 2025-02-11 | 17:27 ET | [8-K](/filings/0001493152-25-005961.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-005961 |
| 2024-11-18 | 19:58 ET | [SC 13D](/filings/0001493152-24-046638.md) | Ownership report, active investor | 0001493152-24-046638 |
| 2024-11-18 | 19:58 ET | [SC 13D](/filings/0001493152-24-046637.md) | Ownership report, active investor | 0001493152-24-046637 |
| 2024-11-18 | 19:58 ET | [SC 13D](/filings/0001493152-24-046636.md) | Ownership report, active investor | 0001493152-24-046636 |
| 2024-11-18 | 19:58 ET | [SC 13D](/filings/0001493152-24-046639.md) | Ownership report, active investor | 0001493152-24-046639 |
| 2024-11-18 | 16:45 ET | [8-K](/filings/0001493152-24-046545.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-046545 |
| 2024-11-12 | 16:55 ET | [10-Q](/filings/0001493152-24-044813.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044813 |
| 2024-10-21 | 11:23 ET | [S-1/A](/filings/0001493152-24-041726.md) | Registration statement, amended | 0001493152-24-041726 |
| 2024-10-04 | 17:28 ET | [S-1/A](/filings/0001493152-24-039580.md) | Registration statement, amended | 0001493152-24-039580 |
| 2024-09-19 | 14:03 ET | [S-1/A](/filings/0001493152-24-037099.md) | Registration statement, amended | 0001493152-24-037099 |
| 2024-09-06 | 16:25 ET | [S-1/A](/filings/0001493152-24-035313.md) | Registration statement, amended | 0001493152-24-035313 |
| 2024-08-01 | 06:11 ET | [S-1/A](/filings/0001493152-24-029826.md) | Registration statement, amended | 0001493152-24-029826 |
| 2024-05-22 | 16:40 ET | [S-1/A](/filings/0001493152-24-021024.md) | Registration statement, amended | 0001493152-24-021024 |
| 2024-04-17 | 16:07 ET | [S-1/A](/filings/0001493152-24-015031.md) | Registration statement, amended | 0001493152-24-015031 |
| 2024-02-14 | 10:46 ET | [S-1/A](/filings/0001493152-24-006408.md) | Registration statement, amended | 0001493152-24-006408 |
| 2024-02-09 | 16:58 ET | [S-1](/filings/0001493152-24-005725.md) | Registration statement | 0001493152-24-005725 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 15:02 ET. No prices; not investment advice.